Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wechsler

Showing results (41-50 of 213) with videos related to

Pageof 22
Sort By:
Virology|September 1, 1992
Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challengeH Ghiasi, R Kaiwar, A B Nesburn, et al.
The Journal of General Virology|August 1, 1989
In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1J Zwaagstra, H Ghiasi, A B Nesburn, et al.
Digestive Diseases and Sciences|July 1, 1989
A watershed in gallstone therapy?R R Schade, D H Van Thiel, R L Wechsler
Archives of Virology|January 1, 1991
Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein DH Ghiasi, A B Nesburn, R Kaiwar, et al.
Current Eye Research|December 13, 1997
MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1H Ghiasi, S Cai, A B Nesburn, et al.
Future Microbiology|December 22, 2009
Developing an asymptomatic mucosal herpes vaccine: the present and the futureGargi Dasgupta, Anthony B Nesburn, Steven L Wechsler, et al.
Antiviral Research|June 1, 1992
Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infectionH Ghiasi, R Kaiwar, A B Nesburn, et al.
Digestive Diseases and Sciences|January 1, 1988
Digestive Diseases and Sciences: Its new editors and their policyR L Wechsler, R R Schade, D H Van Thiel
Virus Research|January 1, 1992
Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological propertiesH Ghiasi, R Kaiwar, A B Nesburn, et al.
Virology|August 1, 1982
The protease inhibitor TLCK alters the apparent molecular weights of some measles virus proteins by a mechanism unrelated to inhibition of proteolytic cleavageS L Wechsler, S Weyand, A Goosmann, et al.
Pageof 22

Showing results (41-50 of 213) with videos related to

Sort By:
Pageof 22
Virology|September 1, 1992
Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challengeH Ghiasi, R Kaiwar, A B Nesburn, et al.
The Journal of General Virology|August 1, 1989
In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1J Zwaagstra, H Ghiasi, A B Nesburn, et al.
Digestive Diseases and Sciences|July 1, 1989
A watershed in gallstone therapy?R R Schade, D H Van Thiel, R L Wechsler
Archives of Virology|January 1, 1991
Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein DH Ghiasi, A B Nesburn, R Kaiwar, et al.
Current Eye Research|December 13, 1997
MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1H Ghiasi, S Cai, A B Nesburn, et al.
Future Microbiology|December 22, 2009
Developing an asymptomatic mucosal herpes vaccine: the present and the futureGargi Dasgupta, Anthony B Nesburn, Steven L Wechsler, et al.
Antiviral Research|June 1, 1992
Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infectionH Ghiasi, R Kaiwar, A B Nesburn, et al.
Digestive Diseases and Sciences|January 1, 1988
Digestive Diseases and Sciences: Its new editors and their policyR L Wechsler, R R Schade, D H Van Thiel
Virus Research|January 1, 1992
Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological propertiesH Ghiasi, R Kaiwar, A B Nesburn, et al.
Virology|August 1, 1982
The protease inhibitor TLCK alters the apparent molecular weights of some measles virus proteins by a mechanism unrelated to inhibition of proteolytic cleavageS L Wechsler, S Weyand, A Goosmann, et al.
Pageof 22